頁籤選單縮合
| 題 名 | 我國實驗室生物安全管理之進展及精進=Progress and Refinement of Laboratory Biosafety Management in Taiwan |
|---|---|
| 作 者 | 吳文超; 蔡威士; 呂沛穎; 陳奕禎; | 書刊名 | 疫情報導 |
| 卷 期 | 38:20 2022.10.18[民111.10.18] |
| 頁 次 | 頁284-291 |
| 分類號 | 412.42 |
| 關鍵詞 | 實驗室生物安全; 高防護實驗室; 實驗室感染; 生物安全主管; 生物風險管理系統; Laboratory biosafety; High-containment laboratory; Laboratory-acquired infections; Biosafety officer; Biorisk management system; |
| 語 文 | 中文(Chinese) |
| 中文摘要 | 當2020年初,中國大陸武漢地區發生「嚴重特殊傳染性肺炎」(COVID-19)後,疾病管制署因疫情升溫,不久即成立「嚴重特殊傳染性肺炎中央流行疫情指揮中心」,啟動跨部會整備工作並持續充實各項防疫能量。對於實驗室生物安全管理方面,展開相關因應整備措施,包括「研訂生物安全規範」、「單位進行自我檢核」、「政府執行外部查核」、「落實病原移轉管制」以及「運用資訊系統管理」等五大策略,以確保從事新型冠狀病毒(SARS-CoV-2)相關檢驗及研究單位之實驗室生物安全無虞。雖然,於2021年底不幸發生高防護實驗室人員感染COVID-19意外,但疫情指揮中心立即啟動應變機制,順利完成意外事件調查,並要求肇事單位完成清消、矯正及復原計畫,經指揮中心確認無安全疑慮,始可重新啟用。顯示我國對於重大生物安全危害事件,已具備快速處理及應變能力。造成此次意外肇因係為實驗室人員未確實遵循個人防護及實驗操作相關標準作業程序,實驗室主管對於生物安全管理認知偏差,與生物安全會未落實內部稽核及有效監督所致。為此,疾病管制署加速推動生物安全主管專人監督制度及落實高防護實驗室導入生物風險管理系統之修法,以精進我國實驗室生物安全管理水準。 |
| 英文摘要 | In early 2020, following the outbreak of COVID-19 in Wuhan, China, Taiwan Centers for Disease Control (Taiwan CDC) responded to the epidemic by establishing the Central Epidemic Command Center (CECC) for COVID-19 to initiate interdepartmental preparations and continue to build up epidemic prevention capacity. In terms of laboratory biosafety management, five major strategies had been implemented to ensure biosafety in laboratories engaged in novel coronavirus (SARS-CoV-2) related testing and research units, including "developing biosafety guidelines," "requiring institutional self-audit," "implementing external government inspection," "implementing pathogen transfer control" and "using information system management". Despite the accident of COVID-19 infection in a high-containment laboratory at the end of 2021, the CECC immediately activated the response mechanism, investigated the accident, and required the institution in question to complete the decontamination, correction and recovery plan. This showed that Taiwan has the ability to handle and respond quickly to major biosafety hazards. The cause of the accident was that the laboratory personnel did not follow the standard operating procedures related to personal protection equipment and laboratory operations, the laboratory supervisor had a misunderstanding of biosafety management, and the biosafety committee did not implement internal auditing and effective supervision. For this reason, Taiwan CDC had accelerated the implementation of a biosafety officer supervision system and the introduction of a biorisk management system in high-containment laboratories to improve the biosafety management level of laboratories in Taiwan. |
本系統中英文摘要資訊取自各篇刊載內容。